This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Oxolinic acid
- DrugBank Accession Number
- DB13627
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Oxolinic acid (DB13627)
- Weight
- Average: 261.2301
Monoisotopic: 261.063722467 - Chemical Formula
- C13H11NO5
- Synonyms
- ácido oxolínico
- Oxolinic acid
- External IDs
- NSC-110364
- W 4565
- W-4565
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Oxolinic acid. Aceclofenac Aceclofenac may increase the neuroexcitatory activities of Oxolinic acid. Acemetacin Acemetacin may increase the neuroexcitatory activities of Oxolinic acid. Acenocoumarol The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Oxolinic acid. Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Oxolinic acid. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
Categories
- ATC Codes
- J01MB05 — Oxolinic acid
- Drug Categories
- 4-Quinolones
- Anti-Bacterial Agents
- Anti-Infective Agents
- Anti-Infective Agents, Urinary
- Antibacterials for Systemic Use
- Antiinfectives for Systemic Use
- Antineoplastic Agents
- Enzyme Inhibitors
- Fluoroquinolones
- Heterocyclic Compounds, Fused-Ring
- Potential QTc-Prolonging Agents
- QTc Prolonging Agents
- Quinolines
- Quinolones
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Quinolines and derivatives
- Sub Class
- Quinoline carboxylic acids
- Direct Parent
- Quinoline carboxylic acids
- Alternative Parents
- Hydroquinolones / Hydroquinolines / Pyridinecarboxylic acids / Benzodioxoles / Benzenoids / Vinylogous amides / Heteroaromatic compounds / Acetals / Azacyclic compounds / Oxacyclic compounds show 6 more
- Substituents
- Acetal / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Benzodioxole / Carboxylic acid / Carboxylic acid derivative / Dihydroquinoline / Dihydroquinolone / Heteroaromatic compound show 14 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- organic heterotricyclic compound, oxacycle, quinolone antibiotic, quinolinemonocarboxylic acid, aromatic carboxylic acid (CHEBI:138856) / Quinone fungicides (C11342)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- L0A22B22FT
- CAS number
- 14698-29-4
- InChI Key
- KYGZCKSPAKDVKC-UHFFFAOYSA-N
- InChI
- InChI=1S/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17)
- IUPAC Name
- 5-ethyl-8-oxo-2H,5H,8H-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
- SMILES
- CCN1C=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12
References
- General References
- Not Available
- External Links
- KEGG Drug
- D02301
- KEGG Compound
- C11342
- ChemSpider
- 4467
- 7798
- ChEBI
- 138856
- ChEMBL
- CHEMBL416755
- ZINC
- ZINC000000001875
- PDBe Ligand
- OXI
- Wikipedia
- Oxolinic_acid
- PDB Entries
- 1kse
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 1.91 mg/mL ALOGPS logP 0.86 ALOGPS logP 1.35 Chemaxon logS -2.1 ALOGPS pKa (Strongest Acidic) 5.39 Chemaxon pKa (Strongest Basic) -4.3 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 76.07 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 65.84 m3·mol-1 Chemaxon Polarizability 25.52 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 163.6864257 predictedDarkChem Lite v0.1.0 [M-H]- 167.9017195 predictedDarkChem Lite v0.1.0 [M-H]- 156.84016 predictedDeepCCS 1.0 (2019) [M+H]+ 160.8204148 predictedDarkChem Lite v0.1.0 [M+H]+ 168.2463195 predictedDarkChem Lite v0.1.0 [M+H]+ 159.19817 predictedDeepCCS 1.0 (2019) [M+Na]+ 167.6314155 predictedDarkChem Lite v0.1.0 [M+Na]+ 167.8855195 predictedDarkChem Lite v0.1.0 [M+Na]+ 165.2913 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:45 / Updated at February 21, 2021 18:54